{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-005237","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.920430+00:00","generated_at":"2026-05-27T19:21:51.247086+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DarioHealth closes $25.6M private placement; targets cash flow positive by end of 2025","bullets":["Raised $25.6M via convertible preferred stock at conversion prices of $0.73 and $0.83; majority from existing shareholders.","Pro forma cash balance of $40.6M as of Q3 2024; aims to achieve operational cash flow positive run rate by end of 2025.","Preferred stock pays 10% quarterly stock dividend for first four quarters; conversion subject to stockholder approval.","Lock-up agreements with Series B & C preferred holders to receive up to 40% additional common shares over 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-005237","json":"https://secwatch.observer/filing/0001104659-25-005237.json","markdown":"https://secwatch.observer/filing/0001104659-25-005237.md","text":"https://secwatch.observer/filing/0001104659-25-005237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925005237/0001104659-25-005237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925005237/tm254039d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T19:21:51.247086+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}